Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Vir Biotechnology, Inc. VIR

Full chart Compare
Set alert

Price alert · VIR

All alert types
11.22 USD 0.00 (+0.00%)

At closeNov 4, 2026, 8:59 AM EST

11.47 +0.25 +2.23%

Pre-market · Nov 4, 8:59 AM ET

Day range unavailable

4.82 52-week range 12.19
YTD
+86.07%
1 year
+113.71%

Financial health

Altman Z-Score

3.48 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 3
  • P/E 1
  • P/B 4

Valuation

P/E -1.9×
FY 2017: -1.4×FY 2018: -11.7×FY 2019: -7.8×FY 2020: -10.7×FY 2021: 10.3×FY 2022: 6.5×FY 2023: -2.2×FY 2024: -1.9×FY 2025: -1.9×
FY 2017 5y median -1.9× FY 2025
P/S 12.2×
FY 2017: 36.1×FY 2018: 127×FY 2019: 167×FY 2020: 41.8×FY 2021: 5.0×FY 2022: 2.1×FY 2023: 15.7×FY 2024: 13.5×FY 2025: 12.2×
FY 2017 5y median 12.2× FY 2025
P/B 1.1×
FY 2017: -1.4×FY 2018: -7.6×FY 2019: 3.2×FY 2020: 4.5×FY 2021: 3.8×FY 2022: 1.6×FY 2023: 0.8×FY 2024: 0.9×FY 2025: 1.1×
FY 2017 5y median 1.1× FY 2025
P/FCF -2.1×
FY 2017: -1.4×FY 2018: -13.3×FY 2019: -9.8×FY 2020: -16.2×FY 2021: -78.4×FY 2022: 2.1×FY 2023: -1.7×FY 2024: -2.2×FY 2025: -2.1×
FY 2017 5y median -2.1× FY 2025
EV/EBITDA -1.7×
FY 2017: 1.1×FY 2018: -11.4×FY 2019: -7.4×FY 2020: -9.8×FY 2021: 12.1×FY 2022: 3.1×FY 2023: -1.9×FY 2024: -1.7×FY 2025: -1.7×
FY 2017 5y median -1.7× FY 2025
EV/Sales 11.5×
FY 2017: -33.3×FY 2018: 124×FY 2019: 154×FY 2020: 37.0×FY 2021: 4.8×FY 2022: 1.6×FY 2023: 14.3×FY 2024: 11.8×FY 2025: 11.5×
FY 2017 5y median 11.5× FY 2025
FCF Yield -47.5%
FY 2017: -70.7%FY 2018: -7.5%FY 2019: -10.2%FY 2020: -6.2%FY 2021: -1.3%FY 2022: 47.5%FY 2023: -59.3%FY 2024: -45.4%FY 2025: -47.5%
FY 2017 5y median -45.4% FY 2025

Profitability

Gross Margin 82.9%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 93.5%FY 2022: 90.0%FY 2023: 74.2%FY 2024: 79.2%FY 2025: 82.9%
FY 2017 5y median 82.9% FY 2025
Operating Margin -682.7%
FY 2017: -2983.6%FY 2018: -1112.6%FY 2019: -2144.3%FY 2020: -387.8%FY 2021: 38.4%FY 2022: 51.6%FY 2023: -767.0%FY 2024: -705.4%FY 2025: -682.7%
FY 2017 5y median -682.7% FY 2025
Net Margin -638.9%
FY 2017: -2579.5%FY 2018: -1086.3%FY 2019: -2159.0%FY 2020: -391.1%FY 2021: 48.3%FY 2022: 31.9%FY 2023: -713.7%FY 2024: -703.4%FY 2025: -638.9%
FY 2017 5y median -638.9% FY 2025
ROE -57.2%
FY 2017: 101.4%FY 2018: 64.7%FY 2019: -41.2%FY 2020: -41.7%FY 2021: 36.9%FY 2022: 24.8%FY 2023: -38.7%FY 2024: -45.4%FY 2025: -57.2%
FY 2017 5y median -38.7% FY 2025
ROIC -50.9%
FY 2017: -29.2%FY 2018: -77.9%FY 2019: -38.3%FY 2020: -36.0%FY 2021: 25.0%FY 2022: 24.8%FY 2023: -36.8%FY 2024: -40.6%FY 2025: -50.9%
FY 2017 5y median -36.8% FY 2025
ROA -43.7%
FY 2017: -27.8%FY 2018: -60.5%FY 2019: -34.1%FY 2020: -32.5%FY 2021: 27.0%FY 2022: 18.4%FY 2023: -32.1%FY 2024: -37.3%FY 2025: -43.7%
FY 2017 5y median -32.1% FY 2025

Growth (YoY)

Revenue -7.6%
FY 2017: 0.0%FY 2018: 293.9%FY 2019: -24.2%FY 2020: 843.9%FY 2021: 1334.4%FY 2022: 47.5%FY 2023: -94.7%FY 2024: -13.9%FY 2025: -7.6%
FY 2017 FY 2025
Operating Income 10.6%
FY 2017: 0.0%FY 2018: -46.9%FY 2019: -46.2%FY 2020: -70.7%FY 2021: 242.1%FY 2022: 98.0%FY 2023: -179.3%FY 2024: 20.8%FY 2025: 10.6%
FY 2017 FY 2025
EPS (diluted) 17.5%
FY 2017: 0.0%FY 2018: 88.0%FY 2019: -35.0%FY 2020: -54.9%FY 2021: 257.8%FY 2022: -3.3%FY 2023: -219.8%FY 2024: 16.6%FY 2025: 17.5%
FY 2017 FY 2025
Free Cash Flow 12.6%
FY 2017: 0.0%FY 2018: -48.0%FY 2019: -35.5%FY 2020: -42.5%FY 2021: 64.9%FY 2022: 2398.4%FY 2023: -150.2%FY 2024: 43.3%FY 2025: 12.6%
FY 2017 FY 2025

Financial Health

Current Ratio 5.5×
FY 2017: 15.5×FY 2018: 3.0×FY 2019: 6.8×FY 2020: 7.8×FY 2021: 4.6×FY 2022: 4.9×FY 2023: 9.1×FY 2024: 8.7×FY 2025: 5.5×
FY 2017 5y median 5.5× FY 2025
Quick Ratio 5.5×
FY 2017: 15.5×FY 2018: 3.0×FY 2019: 6.8×FY 2020: 7.8×FY 2021: 4.6×FY 2022: 4.9×FY 2023: 9.1×FY 2024: 8.7×FY 2025: 5.5×
FY 2017 5y median 5.5× FY 2025
Debt / Equity 0.2×
FY 2017: 0.0×FY 2018: -0.1×FY 2019: 0.0×FY 2020: 0.1×FY 2021: 0.1×FY 2022: 0.1×FY 2023: 0.1×FY 2024: 0.1×FY 2025: 0.2×
FY 2017 5y median 0.1× FY 2025
Net Debt / EBITDA 0.1×
FY 2017: 2.3×FY 2018: 0.3×FY 2019: 0.6×FY 2020: 1.3×FY 2021: -0.5×FY 2022: -0.8×FY 2023: 0.2×FY 2024: 0.2×FY 2025: 0.1×
FY 2017 5y median 0.1× FY 2025
Interest Coverage 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2017 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31